HLA-DRB1 and myeloid sarcoma: Given the documented genetic association of HLA class II haplotype DRB1*1501 with MS susceptibility (37), we next asked whether clonal expansion differed by HLA-DRB1*1501 type (–/+) and found that HLA class II type impacts on CD4+ clonal expansion (Figure S2A).